{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:56:44Z","timestamp":1793051804000,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Advances in prenatal screening and early diagnosis of genetic disease will potentially allow for preemptive treatment of anticipated postnatal disease by in utero cell transplantation (IUCT). This strategy carries potential benefits over postnatal treatment, which might allow for improved engraftment and function of the transplanted cells. Congenital metabolic disorders may be an ideal target for this type of therapy, as in most cases, they require replacement of a single deficient hepatic enzyme, and multiple small-animal models exist for preclinical testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>The Gunn rat, a Crigler\u2013Najjar syndrome model animal lacking UDP-glucuronosyltransferase (UGT1A1), was used as recipient. Human amniotic epithelial cells (hAECs), which possess hepatic differentiation potential, were transplanted into the midgestation fetal Gunn rat liver via ultrasound-guided IUCT. The impact of IUCT on live birth and postnatal survival was evaluated. Human cell engraftment was immunohistochemically analyzed on postnatal day 21.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Ultrasound-guided IUCT was conducted in rat fetuses on embryonic day 16. Following IUCT, the antihuman mitochondria-positive cells were detected in the liver of recipient rats at postnatal day 21.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Here, we have introduced ultrasound-guided IUCT of hAEC using a small-animal model of a congenital metabolic disorder without immunosuppression. The immunological advantage of IUCT was demonstrated with xenogeneic IUCT. This procedure is suitable to conduct preclinical studies for exploring the feasibility and efficacy of ultrasound-guided transuterine cell injection using rodent disease models.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002735","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T11:25:58Z","timestamp":1555154758000},"page":"e182-e187","source":"Crossref","is-referenced-by-count":9,"title":["Ultrasound-guided in Utero Transplantation of Placental Stem Cells into the Liver of Crigler\u2013Najjar Syndrome Model Rat"],"prefix":"10.1097","volume":"103","author":[{"given":"Brendan H.","family":"Grubbs","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mc Millan","family":"Ching","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Parducho","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramen H.","family":"Chmait","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","first-page":"278","article-title":"In utero hematopoietic cell transplantation for hemoglobinopathies.","volume":"5","author":"Derderian","year":"2014","journal-title":"Front Pharmacol"},{"key":"R2-20231002","first-page":"282","article-title":"Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT).","volume":"5","author":"Loewendorf","year":"2014","journal-title":"Front Pharmacol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrgastro.2010.44","article-title":"Human hepatocyte transplantation: current experience and future challenges.","volume":"7","author":"Dhawan","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e31823b72d6","article-title":"Current status of hepatocyte transplantation.","volume":"93","author":"Hughes","year":"2012","journal-title":"Transplantation"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00109-018-1638-5","article-title":"Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine.","volume":"96","author":"Lee","year":"2018","journal-title":"J Mol Med (Berl)"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.","volume":"338","author":"Fox","year":"1998","journal-title":"N Engl J Med"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3727\/000000005783983250","article-title":"Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1.","volume":"14","author":"Ambrosino","year":"2005","journal-title":"Cell Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3748\/wjg.14.3464","article-title":"Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.","volume":"14","author":"Lysy","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem cell characteristics of amniotic epithelial cells.","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cells"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jog.12213","article-title":"Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives.","volume":"40","author":"Miki","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.24255","article-title":"Hepatic differentiation of amniotic epithelial cells.","volume":"53","author":"Marongiu","year":"2011","journal-title":"Hepatology"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clp.2009.03.006","article-title":"Prenatal stem cell transplantation and gene therapy.","volume":"36","author":"Santore","year":"2009","journal-title":"Clin Perinatol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/pd.443","article-title":"Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).","volume":"22","author":"Francoual","year":"2002","journal-title":"Prenat Diagn"},{"issue":"Chapter 1","key":"R14-20231002","first-page":"1","article-title":"Isolation of amniotic epithelial stem cells.","author":"Miki","year":"2010","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13287-015-0258-z","article-title":"Biological impact of xeno-free chemically defined cryopreservation medium on amniotic epithelial cells.","volume":"7","author":"Miki","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(89)92819-5","article-title":"In-utero transplantation of stem cells in bare lymphocyte syndrome.","volume":"1","author":"Touraine","year":"1989","journal-title":"Lancet"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(96)09392-0","article-title":"In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI).","volume":"348","author":"Wengler","year":"1996","journal-title":"Lancet"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"562037","DOI":"10.1155\/2013\/562037","article-title":"In utero hepatocellular transplantation in rats.","volume":"2013","author":"Mu\u00f1oz-S\u00e1ez","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1172\/JCI115701","article-title":"Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.","volume":"89","author":"Zanjani","year":"1992","journal-title":"J Clin Invest"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5966\/sctm.2015-0304","article-title":"A rational strategy for the use of amniotic epithelial stem cell therapy for liver diseases.","volume":"5","author":"Miki","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J Exp Med"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.humimm.2016.07.002","article-title":"Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease.","volume":"77","author":"Strom","year":"2016","journal-title":"Hum Immunol"},{"key":"R24-20231002","first-page":"1539","article-title":"Immunogenicity of human amniotic membrane in experimental xenotransplantation.","volume":"42","author":"Kubo","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.818706","article-title":"Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats.","volume":"192","author":"Matas","year":"1976","journal-title":"Science"},{"key":"R26-20231002","first-page":"313","article-title":"Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation.","volume":"9","author":"Groth","year":"1977","journal-title":"Transplant Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:28:05Z","timestamp":1696224485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002735","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}